PMCTPharmaCountry
    Home

Regulatory Updates

FDA, EMA, TGA and global regulatory developments

#2808 ×

UPDATED
Regulatory Updates
Sep 2, 2026•1 min read
FDA Approves ANDA207047 for Clindamycin Palmitate Hydrochloride
The FDA has approved ANDA207047 for an oral clindamycin palmitate hydrochloride solution (75 mg/5 ml) marketed by Heritage Pharmaceuticals under sponsor APPCO.